Clinical Trial Update: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating donor stem cell or donor white blood cell infusions in hematologic cancers; the study is terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Unusual Cancers of Childhood

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2012-06-19